drugset / Trial / NCT02287415
The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin
NaSingle-groupOpen-labelTreatment
Summary
Multiple-dose, open-label, single-period study consisting of three consecutive phases
Timeline
- Start
- 2002-05
- Primary completion
- 2002-07
- Completion
- 2002-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | — | — |
| Subject | Warfarin | Small molecule | — | — |